Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
US8680246B2 · kind B2 · utility
12Cited by
70References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2011 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Nov 4, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides lysyl oxidase-like-2 (LOXL2) polypeptide binding agents, including, for example, antibodies that specifically bind a LOXL2 polypeptide; and further provides compositions comprising same. The binding agents can be used in various treatment and diagnostic methods, which are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.